Stockreport

Kamada up 4% on Q3 results [Seeking Alpha]

NOVELION THERAPEUTICS INC COMMON SHARES  (NVLN) 
Last novelion therapeutics inc common shares earnings: 5/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.novelion.com
PDF Kamada ( KMDA ) Q3 results : Revenues: $15M (-34.5%). Net Loss: ($2.4M); Loss Per Share: ($0.06); CF Flow Ops (3M): $1M. 2018 Guidance : Revenues: $102M - [Read more]